Table 3.
Intraoperative and postoperative data
| Parameter | 1-year survivors (N = 212) | 1-year nonsurvivors (N = 86) | P value |
|---|---|---|---|
| dLVAD type, n (%) | .508 | ||
| HeartWare HVAD | 88 (41.5) | 40 (46.5) | |
| HeartMate 3 | 124 (58.5) | 46 (53.5) | |
| Surgical data | |||
| Implantation on CPB, n (%) | 144 (69.6) | 59 (72.8) | .686 |
| Implantation on ECLS, n (%) | 39 (20.1) | 18 (23.7) | .629 |
| Minimally invasive surgery, n (%) | 15 (7.5) | 6 (8.0) | 1.000 |
| Concomitant valve surgery, n (%) | 13 (6.1) | 12 (14.0) | .048 |
| Surgery time, min, median (IQR) | 234.00 (170.00-290.00) | 250.00 (199.25-300.00) | .069 |
| Postoperative complications | |||
| Chest tube output 24 h after surgery, mL, median (IQR) | 600.00 (360.00-1200.00) | 800.00 (361.25-1310.00) | .210 |
| FFP during and within 24 h after surgery, units, median (IQR) | 6.00 (4.00-8.00) | 6.00 (4.00-9.00) | .420 |
| PRBC during and within 24 h after surgery, units, median (IQR) | 5.00 (3.00-8.00) | 7.00 (4.25-11.00) | <.001 |
| Platelet concentrates during and within 24 h after surgery, units, median (IQR) | 2.00 (0.00-4.00) | 3.00 (2.00-5.00) | .064 |
| Right heart failure requiring RVAD implantation, n (%) | 33 (15.6) | 34 (39.5) | <.001 |
| Time of right heart failure, n (%) | <.001 | ||
| Early intraoperative | 24 (10.8) | 24 (27.9) | |
| Early postoperative | 8 (3.8) | 9 (10.5) | |
| Late | 2 (0.9) | 1 (1.2) | |
| Weaning from RVAD, n (%) | 27 (75.0) | 12 (35.3) | <.001 |
| Duration of RVAD support, d, median (IQR) | 21.00 (13.00-25.00) | 16.00 (10.00-22.00) | .113 |
dLVAD, Durable left ventricular assist device; CPB, cardiopulmonary bypass; ECLS, extracorporeal life support; IQR, interquartile range; FFP, fresh frozen plasma; PRBC, packed red blood cells; RVAD, right ventricular assist device.